364 related articles for article (PubMed ID: 31493234)
1. Ion Mobility Spectrometry: Fundamental Concepts, Instrumentation, Applications, and the Road Ahead.
Dodds JN; Baker ES
J Am Soc Mass Spectrom; 2019 Nov; 30(11):2185-2195. PubMed ID: 31493234
[TBL] [Abstract][Full Text] [Related]
2. Targeted glucocorticoid analysis using ion mobility-mass spectrometry (IM-MS).
Neal SP; Wilson KM; Velosa DC; Chouinard CD
J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():50-56. PubMed ID: 35469203
[TBL] [Abstract][Full Text] [Related]
3. Combining Isotopologue Workflows and Simultaneous Multidimensional Separations to Detect, Identify, and Validate Metabolites in Untargeted Analyses.
Dodds JN; Wang L; Patti GJ; Baker ES
Anal Chem; 2022 Feb; 94(5):2527-2535. PubMed ID: 35089687
[TBL] [Abstract][Full Text] [Related]
4. Lipid analysis by ion mobility spectrometry combined with mass spectrometry: A brief update with a perspective on applications in the clinical laboratory.
Dubland JA
J Mass Spectrom Adv Clin Lab; 2022 Jan; 23():7-13. PubMed ID: 34988541
[TBL] [Abstract][Full Text] [Related]
5. Recent applications of ion mobility spectrometry in natural product research.
Masike K; Stander MA; de Villiers A
J Pharm Biomed Anal; 2021 Feb; 195():113846. PubMed ID: 33422832
[TBL] [Abstract][Full Text] [Related]
6. AutoCCS: automated collision cross-section calculation software for ion mobility spectrometry-mass spectrometry.
Lee JY; Bilbao A; Conant CR; Bloodsworth KJ; Orton DJ; Zhou M; Wilson JW; Zheng X; Webb IK; Li A; Hixson KK; Fjeldsted JC; Ibrahim YM; Payne SH; Jansson C; Smith RD; Metz TO
Bioinformatics; 2021 Nov; 37(22):4193-4201. PubMed ID: 34145874
[TBL] [Abstract][Full Text] [Related]
7. A re-calibration procedure for interoperable lipid collision cross section values measured by traveling wave ion mobility spectrometry.
George AC; Schmitz-Afonso I; Marie V; Colsch B; Fenaille F; Afonso C; Loutelier-Bourhis C
Anal Chim Acta; 2022 Sep; 1226():340236. PubMed ID: 36068052
[TBL] [Abstract][Full Text] [Related]
8. Interplatform comparison between three ion mobility techniques for human plasma lipid collision cross sections.
George AC; Schmitz I; Rouvière F; Alves S; Colsch B; Heinisch S; Afonso C; Fenaille F; Loutelier-Bourhis C
Anal Chim Acta; 2024 May; 1304():342535. PubMed ID: 38637036
[TBL] [Abstract][Full Text] [Related]
9. Integrating ion mobility and imaging mass spectrometry for comprehensive analysis of biological tissues: A brief review and perspective.
Rivera ES; Djambazova KV; Neumann EK; Caprioli RM; Spraggins JM
J Mass Spectrom; 2020 Dec; 55(12):e4614. PubMed ID: 32955134
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry.
Paglia G; Astarita G
Nat Protoc; 2017 Apr; 12(4):797-813. PubMed ID: 28301461
[TBL] [Abstract][Full Text] [Related]
11. Rapid Characterization of Per- and Polyfluoroalkyl Substances (PFAS) by Ion Mobility Spectrometry-Mass Spectrometry (IMS-MS).
Dodds JN; Hopkins ZR; Knappe DRU; Baker ES
Anal Chem; 2020 Mar; 92(6):4427-4435. PubMed ID: 32011866
[TBL] [Abstract][Full Text] [Related]
12. Integrating ion mobility into comprehensive multidimensional metabolomics workflows: critical considerations.
May JC; McLean JA
Metabolomics; 2022 Dec; 18(12):104. PubMed ID: 36472678
[TBL] [Abstract][Full Text] [Related]
13. Ion mobility-mass spectrometry.
Kanu AB; Dwivedi P; Tam M; Matz L; Hill HH
J Mass Spectrom; 2008 Jan; 43(1):1-22. PubMed ID: 18200615
[TBL] [Abstract][Full Text] [Related]
14. Applications of ion-mobility mass spectrometry for lipid analysis.
Paglia G; Kliman M; Claude E; Geromanos S; Astarita G
Anal Bioanal Chem; 2015 Jul; 407(17):4995-5007. PubMed ID: 25893801
[TBL] [Abstract][Full Text] [Related]
15. Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urine.
Hernández-Mesa M; Monteau F; Le Bizec B; Dervilly-Pinel G
Anal Chim Acta X; 2019 Mar; 1():100006. PubMed ID: 33117973
[TBL] [Abstract][Full Text] [Related]
16. Complementary methods for structural assignment of isomeric candidate structures in non-target liquid chromatography ion mobility high-resolution mass spectrometric analysis.
Akhlaqi M; Wang WC; Möckel C; Kruve A
Anal Bioanal Chem; 2023 Sep; 415(21):5247-5259. PubMed ID: 37452839
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive lipidomic analysis of human plasma using multidimensional liquid- and gas-phase separations: Two-dimensional liquid chromatography-mass spectrometry vs. liquid chromatography-trapped-ion-mobility-mass spectrometry.
Baglai A; Gargano AFG; Jordens J; Mengerink Y; Honing M; van der Wal S; Schoenmakers PJ
J Chromatogr A; 2017 Dec; 1530():90-103. PubMed ID: 29146423
[TBL] [Abstract][Full Text] [Related]
18. General Method to Obtain Collision Cross-Section Values in Multipass High-Resolution Cyclic Ion Mobility Separations.
Habibi SC; Nagy G
Anal Chem; 2023 May; 95(20):8028-8035. PubMed ID: 37163363
[TBL] [Abstract][Full Text] [Related]
19. Improving glycan isomeric separation via metal ion incorporation for drift tube ion mobility-mass spectrometry.
Xie C; Wu Q; Zhang S; Wang C; Gao W; Yu J; Tang K
Talanta; 2020 May; 211():120719. PubMed ID: 32070621
[TBL] [Abstract][Full Text] [Related]
20. Enhancing biological analyses with three dimensional field asymmetric ion mobility, low field drift tube ion mobility and mass spectrometry (μFAIMS/IMS-MS) separations.
Zhang X; Ibrahim YM; Chen TC; Kyle JE; Norheim RV; Monroe ME; Smith RD; Baker ES
Analyst; 2015 Oct; 140(20):6955-63. PubMed ID: 26140287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
